- Home
- BUSE vs BHC Comparison
BUSE vs BHC Comparison
Compare BUSE & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BUSE | BHC |
|---|---|---|
| Founded | 1868 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.5B |
| IPO Year | 1996 | 1996 |
Fundamental Metrics
Financial Performance| Metric | BUSE | BHC |
|---|---|---|
| Price | $24.74 | $5.04 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 3 |
| Target Price | ★ $27.00 | $8.33 |
| AVG Volume (30 Days) | 589.1K | ★ 2.1M |
| Earning Date | 04-21-2026 | 04-29-2026 |
| Dividend Yield | ★ 4.22% | N/A |
| EPS Growth | N/A | ★ 423.08 |
| EPS | ★ 1.47 | 0.42 |
| Revenue | $719,584,000.00 | ★ $8,724,000,000.00 |
| Revenue This Year | $23.61 | $4.48 |
| Revenue Next Year | $3.69 | N/A |
| P/E Ratio | $16.72 | ★ $11.96 |
| Revenue Growth | ★ 55.66 | N/A |
| 52 Week Low | $18.40 | $4.28 |
| 52 Week High | $27.65 | $8.69 |
Technical Indicators
Market Signals| Indicator | BUSE | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 45.33 | 36.31 |
| Support Level | $24.09 | $4.93 |
| Resistance Level | $24.90 | $7.22 |
| Average True Range (ATR) | 0.54 | 0.17 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 53.47 | 19.23 |
Price Performance
Historical ComparisonAbout BUSE First Busey Corporation
First Busey Corporation is a financial holding company whose subsidiaries provide retail and commercial banking services, remittance processing, and offer financial products and services with banking centers in Illinois, Missouri, Florida, and Indiana. The company's operations are managed through three operating segments consisting of Banking, FirsTech, and Wealth Management. The banking segment generates a vast majority of its revenue.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.